Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Daina

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2010
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeMarina Noris, Jessica Caprioli, Elena Bresin, et al.
Italian Journal of Pediatrics|September 15, 2020
Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases networkMarco Salvatore, Agata Polizzi, Maria Chiara De Stefano, et al.
Iscience|September 21, 2023
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by NeanderthalsMatteo Breno, Marina Noris, Nadia Rubis, et al.
Digestive Diseases and Sciences|February 4, 2011
Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasiaElisabetta Buscarini, Gioacchino Leandro, Dario Conte, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports|December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyEdwin Wong, Carla Nester, Teresa Cavero, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Kidney International|October 11, 2025
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathyAriela Benigni, Erica Daina, Henry Löffler-Wirth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 23, 2025
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GlomerulonephritisGiliane Nanchen, Maddalena Marasà, Matteo Breno, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2010
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeMarina Noris, Jessica Caprioli, Elena Bresin, et al.
Italian Journal of Pediatrics|September 15, 2020
Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases networkMarco Salvatore, Agata Polizzi, Maria Chiara De Stefano, et al.
Iscience|September 21, 2023
A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by NeanderthalsMatteo Breno, Marina Noris, Nadia Rubis, et al.
Digestive Diseases and Sciences|February 4, 2011
Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasiaElisabetta Buscarini, Gioacchino Leandro, Dario Conte, et al.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.
Kidney International Reports|December 18, 2023
Efficacy and Safety of Iptacopan in Patients With C3 GlomerulopathyEdwin Wong, Carla Nester, Teresa Cavero, et al.
American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.
Kidney International|October 11, 2025
Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathyAriela Benigni, Erica Daina, Henry Löffler-Wirth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 23, 2025
Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GlomerulonephritisGiliane Nanchen, Maddalena Marasà, Matteo Breno, et al.
Pageof 4